Equine β-CTx antibody and antigen (recombinant protein) GMP-EQU-B-CTx

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-EQU-B-CTx-Ag01	Recombinant Equine β-CTx protein	3090
GMP-EQU-B-CTx-Ab01	Anti-Equine β-CTx mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-B-CTx-Ab02	Anti-Equine β-CTx mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-B-CTx-Ab03	Anti-Equine β-CTx mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-B-CTx-Ab04	Anti-Equine β-CTx mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-EQU-B-CTx-Ag01
Product Name	Recombinant Equine β-CTx protein
Target/Biomarker	Equine β-isomerized C-terminal telopeptides (β-CTx)
Expression platform	E.coli
Bioactivity validation	Anti-Equine β-isomerized C-terminal telopeptides antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in β-CTx level test of animal Equine/Horse with osteoporosis.
Tag	His
Products description	Recombinant Equine β-CTx protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	PBS liquid / Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-B-CTx-Ab01, GMP-EQU-B-CTx-Ab02, GMP-EQU-B-CTx-Ab03, GMP-EQU-B-CTx-Ab04
Product Name	Anti-Equine β-CTx mouse monoclonal antibody (mAb)
Target/Biomarker	Equine β-isomerized C-terminal telopeptides (β-CTx)
Expression platform	CHO
Bioactivity validation	Recombinant Equine β-isomerized C-terminal telopeptides antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-β-CTx antibodies in β-CTx level test of animal Equine/Horse with osteoporosis.
Tag	mFc
Products description	Anti-Equine β-CTx mouse monoclonal antibody (mAb) was expressed in CHO.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Equine β-CTx (Beta-CrossLaps) assumes a central role within the Equus ferus caballus species, commonly known as horses. This biomarker is deeply enmeshed in the tapestry of equine bone health, acting as a sentinel of bone resorption, a critical aspect of bone metabolism. Its significance stems from its ability to reflect the dynamic process of breaking down aged or compromised bone tissue within the equine skeletal system. In the intricate landscape of bone metabolism, β-CTx serves as a beacon of bone resorption, a process orchestrated by specialized cells known as osteoclasts. These cells actively participate in the breakdown of bone tissue, releasing fragments of type I collagen, including β-CTx, into the bloodstream. By measuring β-CTx levels, we gain a quantitative insight into the rate at which this resorption process occurs in horses. The importance of Equine β-CTx extends beyond its role as a marker of bone resorption. It is a dynamic reflection of the balance between bone formation and resorption in horses, which is pivotal in maintaining equine skeletal health. Disruptions in this equilibrium, often indicated by changes in β-CTx levels, can be early indicators of bone disorders or diseases.

About GDU